ClinicalTrials.Veeva

Menu
S

Spartanburg Medical Research | Spartanburg, SC

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Semaglutide
Metformin
Tiotropium
Sugar
SUN-101
Lubiprostone
Lasmiditan
PT001
Ensifentrine
Tirzepatide

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

13 of 90 total trials
Status recently updated

A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPD

This study will assess the safety and efficacy of fixed dose combinations of ensifentrine with two different glycopyrrolate dose levels compared to p...

Not yet enrolling
Invitation-only
Chronic Obstructive Pulmonary Disease
Drug: Glycopyrrolate 21.25 mcg
Drug: Ensifentrine 3 mg

This study will look at how well CagriSema helps people living with obesity to lose weight and maintain the weight loss long-term. The study has 2 pa...

Active, not recruiting
Obesity
Drug: Placebo matched to CagriSema (Cagrilintide B and Semaglutide I)
Drug: CagriSema (Cagrilintide B and Semaglutide I)

This study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine develope...

Enrolling
Obesity
Drug: Semaglutide
Drug: Placebo cagrilintide

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigatio...

Active, not recruiting
Type 2 Diabetes
Drug: Semaglutide
Drug: Cagrilintide

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Placebo semaglutide
Drug: Semaglutide

This study will look at how well CagriSema compared to Tirzepatide helps people lower their body weight. CagriSema is a new investigational medicine...

Active, not recruiting
Obesity
Drug: Cagrilintide
Drug: Tirzepatide

This study has 2 parts: First part is the main study and second part is the extension study. During the main study participants will receive 1 of 4 s...

Active, not recruiting
Obesity
Drug: Cagrilintide
Drug: Semaglutide

The primary objectives of this study are to evaluate the safety and reactogenicity of mRNA-1010, and to evaluate relative vaccine efficacy (rVE) of m...

Active, not recruiting
Seasonal Influenza
Biological: Fluarix Tetra
Biological: Fluarix®

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Enrolling
Atopic Dermatitis
Other: Placebo
Drug: PF-07275315

This study is open to adults 40 years or older with idiopathic pulmonary fibrosis (IPF). People can join the study if they are not on any treatment f...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Placebo matching BI 1819479
Drug: BI 1819479

Adults 40 years of age and older with idiopathic pulmonary fibrosis (IPF) or 18 years and older with progressive pulmonary fibrosis (PPF) can partici...

Enrolling
Progressive Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Drug: BI 1839100
Drug: Placebo

The purpose of this study is to evaluate the effectiveness of CD388 in preventing symptomatic laboratory-confirmed influenza infections, as compared...

Active, not recruiting
Influenza
Combination Product: CD388 Injection
Combination Product: Placebo

This study is conducted to see if ziltivekimab reduces the risk of having cardiovascular events (for example heart attack and stroke) in people with...

Active, not recruiting
Chronic Kidney Disease
Inflammation
Drug: Placebo (Ziltivekimab B)
Drug: Placebo (Ziltivekimab C)

Trial sponsors

Novo Nordisk logo
Boehringer Ingelheim logo
Moderna logo
Pfizer logo
Genentech logo
P
S
Sunovion logo
V
AstraZeneca logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems